Medication-induced acute kidney injury

Area of Science:

• Nephrology
• Pharmacology
• Internal Medicine

Background:

• Nephrotoxic medications are a significant cause of acute kidney injury (AKI) in hospitalized individuals.
• Historically, AKI from nephrotoxic drugs was viewed as unavoidable, hindering research into its epidemiology and prevention.
• This perspective limited efforts to reduce the incidence and severity of drug-induced kidney damage.

Purpose of the Study:

• To review the current understanding of nephrotoxic medication-associated AKI.
• To present strategies for minimizing the impact of these medications on kidney function.
• To highlight recent progress in the field and future directions.

Main Methods:

• Review of current literature on nephrotoxic medication-associated AKI.
• Analysis of recent findings regarding risk factors and protective strategies.
• Discussion of ongoing research in biomarkers and genetic susceptibility.

Main Results:

• Recent research has improved the understanding of specific drug combinations and nephrotoxic burden.
• Systematic kidney function assessment has led to reduced AKI rates and severity.
• New initiatives are exploring urinary biomarkers and genetic factors to refine risk prediction.

Conclusions:

• Nephrotoxic medication-associated AKI is a significant clinical problem that is increasingly understood.
• Strategies focusing on drug combinations, burden thresholds, and kidney function monitoring can mitigate AKI.
• Future research involving biomarkers and genetic susceptibility promises further reductions in AKI incidence and severity.